Globus Medical, Inc. (GMED)

Globus Medical Stock Forecast

Stock Price Forecast

The 12 analysts that cover Globus Medical stock have a consensus rating of "Buy" and an average price target of $100.42, which forecasts a 5.20% increase in the stock price over the next year. The lowest target is $64 and the highest is $123.

Price Target: $100.42 (+5.20%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$64	$100.42	$104	$123
Change	-32.96%	+5.20%	+8.95%	+28.85%

Analyst Ratings

The average analyst rating for Globus Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	3	3	5	6	6	5
Buy	5	5	5	5	5	5
Hold	5	6	4	5	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	14	14	16	15	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Vik Chopra Wells Fargo	Wells Fargo	Buy Maintains $98 → $104	Buy	Maintains	$98 → $104	+8.95%	Feb 26, 2026
Matt Miksic Barclays	Barclays	Buy Maintains $118 → $123	Buy	Maintains	$118 → $123	+28.85%	Feb 25, 2026
David Saxon Needham	Needham	Strong Buy Maintains $112 → $114	Strong Buy	Maintains	$112 → $114	+19.42%	Feb 25, 2026
David Saxon Needham	Needham	Hold → Strong Buy Upgrades $112	Hold → Strong Buy	Upgrades	$112	+17.33%	Jan 30, 2026
Caitlin Cronin Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $105 → $112	Strong Buy	Maintains	$105 → $112	+17.33%	Jan 9, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

3.23B

Increased by 9.84%

from 2.94B

Revenue Next Year

3.43B

Increased by 6.13%

from 3.23B

EPS This Year

4.35

Increased by 10.92%

from 3.92

EPS Next Year

4.90

Increased by 12.59%

from 4.35

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	958.10M	1.02B	1.57B	2.52B	2.94B	3.23B	3.43B
Revenue Growth	21.43%	6.76%	53.35%	60.62%	16.65%	9.84%	6.13%
EPS	1.44	1.85	1.07	0.75	3.92	4.35	4.90
EPS Growth	42.57%	28.47%	-42.16%	-29.91%	422.67%	10.92%	12.59%
Forward PE	-	-	-	-	-	21.95	19.50
No. Analysts	-	-	-	-	-	17	14

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	3.4B	3.6B
Avg	3.2B	3.4B
Low	3.0B	3.2B

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	14.9%	11.6%
Avg	9.8%	6.1%
Low	2.5%	-2.4%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	4.62	6.22
Avg	4.35	4.90
Low	3.77	4.23

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	17.9%	43.0%
Avg	10.9%	12.6%
Low	-3.7%	-2.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.